Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.
Breast cancer
Circulating tumor DNA
Circulating tumor cells
Liquid biopsy
Journal
Oncology research
ISSN: 1555-3906
Titre abrégé: Oncol Res
Pays: United States
ID NLM: 9208097
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
12
2022
accepted:
19
05
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Liquid biopsy, including both circulating tumor cells and circulating tumor DNA, is becoming more popular as a diagnostic tool in the clinical management of breast cancer. Elevated concentrations of these biomarkers during cancer treatment may be used as markers for cancer progression as well as to understand the mechanisms underlying metastasis and treatment resistance. Thus, these circulating markers serve as tools for cancer assessing and monitoring through a simple, non-invasive blood draw. However, despite several study results currently noting a potential clinical impact of ctDNA mutation tracking, the method is not used clinically in cancer diagnosis among patients and more studies are required to confirm it. This review focuses on understanding circulating tumor biomarkers, especially in breast cancer.
Identifiants
pubmed: 37547763
doi: 10.32604/or.2023.028406
pii: 28406
pmc: PMC10398400
doi:
Substances chimiques
Circulating Tumor DNA
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
667-675Informations de copyright
© 2023 Alemzadeh et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest to report regarding the present study.
Références
Mol Cancer. 2022 Mar 18;21(1):79
pubmed: 35303879
Nat Methods. 2006 Feb;3(2):95-7
pubmed: 16432518
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
PLoS One. 2011;6(9):e23418
pubmed: 21909401
Cancers (Basel). 2020 Sep 02;12(9):
pubmed: 32887501
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
Cancer Genet. 2018 Dec;228-229:159-168
pubmed: 29572011
J Clin Oncol. 2016 Jun 20;34(18):2115-24
pubmed: 27091708
Clin Cancer Res. 2019 Oct 15;25(20):6089-6097
pubmed: 31358544
Biotechnol Adv. 2018 Jul - Aug;36(4):1063-1078
pubmed: 29559380
Br J Cancer. 2021 Jul;125(1):23-27
pubmed: 33762721
Med Sci Monit. 2020 Mar 22;26:e921040
pubmed: 32200389
N Engl J Med. 2013 Mar 28;368(13):1199-209
pubmed: 23484797
Breast Cancer Res Treat. 2020 Jul;182(1):127-136
pubmed: 32436146
PLoS One. 2018 Mar 16;13(3):e0194630
pubmed: 29547634
Oncotarget. 2017 Sep 1;8(43):75742-75755
pubmed: 29088906
Front Oncol. 2021 Jul 16;11:698551
pubmed: 34336686
Oncol Lett. 2012 Apr 1;3(4):897-900
pubmed: 22741014
Br J Cancer. 2015 May 12;112(10):1652-5
pubmed: 25897674
Clin Chem. 2005 Jan;51(1):113-8
pubmed: 15539466
Breast Cancer Res Treat. 2010 Apr;120(2):461-7
pubmed: 20107891
Clin Cancer Res. 2016 Feb 15;22(4):993-9
pubmed: 26261103
J Egypt Natl Canc Inst. 2022 Feb 21;34(1):8
pubmed: 35187602
Breast Cancer Res. 2014 Aug 09;16(4):421
pubmed: 25107527
Cancer Cell. 2007 Oct;12(4):395-402
pubmed: 17936563
J Clin Oncol. 2016 Sep 1;34(25):2961-8
pubmed: 27269946
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Front Oncol. 2021 Jun 02;11:652253
pubmed: 34150621
Nat Methods. 2006 Jul;3(7):551-9
pubmed: 16791214
Cancers (Basel). 2019 Sep 19;11(9):
pubmed: 31546879
Sci Rep. 2021 Dec 6;11(1):23446
pubmed: 34873218
Sci Transl Med. 2015 Oct 7;7(308):308re8
pubmed: 26446958
Sci Transl Med. 2016 Nov 9;8(364):364ra155
pubmed: 27831904
DNA Cell Biol. 2008 Aug;27(8):415-21
pubmed: 18694299
Cancer Treat Rev. 2019 Feb;73:73-83
pubmed: 30682661
Health Phys. 2016 Mar;110(3):271-3
pubmed: 26808880
BMC Med Genomics. 2021 Apr 13;14(1):102
pubmed: 33849535
Am J Transl Res. 2019 Dec 15;11(12):7209-7222
pubmed: 31934273
Clin Adv Hematol Oncol. 2021 Mar;19(3):155-161
pubmed: 33739964
Cancers (Basel). 2021 Sep 03;13(17):
pubmed: 34503260
Genome Biol. 2018 Mar 15;19(1):33
pubmed: 29544553
Nat Med. 2014 May;20(5):548-54
pubmed: 24705333
J Cancer. 2019 Oct 15;10(24):6095-6104
pubmed: 31762819
Comput Struct Biotechnol J. 2018 Oct 09;16:370-378
pubmed: 30364656
Biosens Bioelectron. 2020 Jan 15;148:111833
pubmed: 31733465
Colloids Surf B Biointerfaces. 2019 Feb 1;174:80-86
pubmed: 30445253
J Hematol Oncol. 2022 Sep 12;15(1):131
pubmed: 36096847
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Front Oncol. 2022 Jul 27;12:921015
pubmed: 35965518
Am J Clin Pathol. 2015 Jan;143(1):18-24
pubmed: 25511138
Ann Glob Health. 2019 Dec 04;85(1):138
pubmed: 31857944
Ann Oncol. 2012 Mar;23(3):618-624
pubmed: 21642515
Breast. 2022 Oct;65:116-123
pubmed: 35926241
Anticancer Res. 2011 Aug;31(8):2623-8
pubmed: 21778314
Br J Cancer. 2014 Mar 4;110(5):1236-43
pubmed: 24473396
Sheng Wu Gong Cheng Xue Bao. 2017 Feb 25;33(2):170-177
pubmed: 28956373
Front Genet. 2022 Feb 16;13:820493
pubmed: 35251131
Theranostics. 2020 Mar 26;10(11):4737-4748
pubmed: 32308746
Exp Mol Pathol. 2016 Apr;100(2):287-93
pubmed: 26626802
Cancers (Basel). 2021 May 13;13(10):
pubmed: 34068368
Pathol Oncol Res. 2020 Oct;26(4):2435-2442
pubmed: 32557169
Int J Mol Sci. 2022 Jul 16;23(14):
pubmed: 35887191
BMC Cancer. 2011 Jan 06;11:4
pubmed: 21211028
Regen Med. 2010 Jul;5(4):531-44
pubmed: 20632857
J Clin Oncol. 2014 Nov 1;32(31):3483-9
pubmed: 24888818
Acta Cytol. 2012;56(6):655-60
pubmed: 23207444
J Transl Med. 2012 Jul 02;10:138
pubmed: 22747748
J Clin Oncol. 2004 Oct 15;22(20):4157-64
pubmed: 15483026
Exp Cell Res. 2015 Jan 1;330(1):123-34
pubmed: 25108138
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424
pubmed: 30796368
Int J Mol Sci. 2020 Mar 21;21(6):
pubmed: 32245182
Nat Commun. 2018 Mar 1;9(1):896
pubmed: 29497091
Sci Transl Med. 2012 Nov 28;4(162):162ra154
pubmed: 23197571
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Science. 2020 Jul 3;369(6499):
pubmed: 32345712
N Engl J Med. 2015 Jun 11;372(24):2353-8
pubmed: 26039523
Clin Cancer Res. 2019 Jun 15;25(12):3581-3588
pubmed: 30862692
Oncol Lett. 2019 Feb;17(2):1409-1416
pubmed: 30675194
Clin Cancer Res. 2018 Jun 1;24(11):2688-2699
pubmed: 29463554
Cancer Lett. 2006 Nov 8;243(1):64-70
pubmed: 16412565
Nat Biotechnol. 2016 May;34(5):547-555
pubmed: 27018799
Nat Med. 2008 Sep;14(9):985-90
pubmed: 18670422
Oncol Lett. 2015 Dec;10(6):3478-3482
pubmed: 26788153
Lancet Oncol. 2020 Oct;21(10):1296-1308
pubmed: 32919527
Lab Chip. 2018 Jan 30;18(3):395-405
pubmed: 29192299
PLoS One. 2014 Oct 31;9(10):e111597
pubmed: 25360587
Sci Transl Med. 2012 May 30;4(136):136ra68
pubmed: 22649089
Mol Oncol. 2011 Feb;5(1):5-23
pubmed: 21147047
Cancers (Basel). 2022 Jan 09;14(2):
pubmed: 35053474
Mol Oncol. 2019 May;13(5):1033-1046
pubmed: 30672098
Nat Commun. 2019 Apr 15;10(1):1749
pubmed: 30988298
Curr Colorectal Cancer Rep. 2016 Jun;12(3):151-161
pubmed: 27516729
Asian Pac J Cancer Prev. 2015;16(14):6081-7
pubmed: 26320499